• Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Rating of "Buy" by Brokerages

    Source: Buzz FX / 28 Nov 2024 03:51:10   America/New_York


    Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Rating of "Buy" by Brokerages Written by MarketBeat November 28, 2024 Share Link copied to clipboard. Day One Biopharmaceuticals, Inc. ( NASDAQ:DAWN - Get Free Report ) has rece
    Read more...
Share on,